Latest Prostate-specific antigen Stories
2014 Cancer Diagnostics Market Opportunities for US, UK, Spain, France, Germany, Italy and Japan analyzes potential applications of various diagnostic technologies and forecasts sales of major
The level of expression of three genes associated with aging can be used to predict whether seemingly low-risk prostate cancer will remain slow-growing.
Men who decide to be screened for prostate cancer and those who forgo PSA screening stick with their decisions after receiving materials explaining the risks and benefits of the test.
Men plan to continue getting prostate-specific antigen (PSA) tests despite recommendations that suggests men should not be screened, according to a new study by researchers at RTI International.
Use of advanced treatment technologies for prostate cancer, such as intensity-modulated radiotherapy and robotic prostatectomy, has increased among men with low-risk disease, high risk of noncancer mortality, or both, a population of patients who are unlikely to benefit from these treatments.
Many men with low-risk, localized prostate cancers can safely choose active surveillance or "watchful waiting" instead of undergoing immediate treatment and have better quality of life while reducing health care costs.
Men’s Cancer Awareness Month in June: Myths about Prostate Cancer Plainview, NY (PRWEB) June 11, 2013 Prostate cancer is the most commonly diagnosed